Sai Ravi Pingali, MD

Assistant Professor of Clinical Medicine in Oncology, Institute for Academic Medicine
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Pingali is board certified by the American Board of Internal Medicine in medical oncology and hematology. His primary focus is on hematologic malignancies and stem cell transplantation. After completing his medical training in India, Dr. Pingali received training in various reputable programs in the United Kingdom as part of senior house officer training after which he moved to the United States. He completed his residency in internal medicine at Gundersen Lutheran Medical Center in Wisconsin. He then completed a fellowship in hematology and oncology at the Medical College of Wisconsin, and a fellowship in stem cell transplantation at the University of Texas MD Anderson Cancer Center.

Dr. Pingali is a member of the American Society of Clinical Oncology, American Society of Hematology and the American Society for Blood and Marrow Transplantation. He sees patients at Houston Methodist Hospital.

Publications

Anemia after continuous-flow left ventricular assist device implantation: Characteristics and implications
Amione-Guerra, J, Cruz-Solbes, AS, Bhimaraj, A, Trachtenberg, BH, Pingali, SR, Estep, JD, Park, MH & Guha, A 2017, International Journal of Artificial Organs, vol 40, no. 9, pp. 481-488. DOI: 10.5301/ijao.5000607

Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma
Pingali, SR, Saliba, RM, Anderlini, P, Hosing, C, Khouri, I, Alousi, AM, Nieto, Y, Qazilbash, MH, Champlin, R & Popat, UR 2017, Biology of Blood and Marrow Transplantation, vol 23, no. 7, pp. 1059-1063. DOI: 10.1016/j.bbmt.2017.03.030

Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation
Kapke, JT, Epperla, N, Shah, N, Richardson, K, Carrum, G, Hari, PN, Pingali, SR, Hamadani, M, Karmali, R & Fenske, TS 2017, Clinical Lymphoma, Myeloma and Leukemia, vol 17, no. 7, pp. 408-414. DOI: 10.1016/j.clml.2017.05.005

High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan
Nieto, Y, Valdez, BC, Pingali, SR, Bassett, R, Delgado, R, Nguyen, J, Shah, N, Popat, U, Jones, RB, Andersson, BS, Gulbis, A, Ahmed, S, Bashir, Q, Parmar, S, Patel, K, Myers, A, Rondon, G, Orlowski, RZ, Champlin, R & Qazilbash, M 2017, The Lancet Haematology, vol 4, no. 6, pp. e283-e292. DOI: 10.1016/S2352-3026(17)30080-7

Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma
Ge, I, Saliba, RM, Maadani, F, Popat, UR, Qazilbash, MH, Ravi Pingali, S, Shah, N, Ahmed, S, Bashir, Q, Nieto, Y, Champlin, RE & Hosing, C 2017, Transfusion. DOI: 10.1111/trf.14016

Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis – a retrospective study from a tertiary center
Nan, X, Qin, Q, Gentille, C, Ensor, J, Leveque, C, Pingali, R, Phan, AT, Rice, L & Iyer, S 2017, Leukemia and Lymphoma, pp. 1-11. DOI: 10.1080/10428194.2016.1277386

Impact of Routine Surveillance Imaging on Outcomes of Patients With Diffuse Large B-Cell Lymphoma After Autologous Hematopoietic Cell Transplantation
Epperla, N, Shah, N, Hamadani, M, Richardson, K, Kapke, JT, Patel, A, Teegavarapu, SP, Carrum, G, Hari, PN, Pingali, SR, Karmali, R & Fenske, TS 2016, Clinical Lymphoma, Myeloma and Leukemia, vol 16, no. 12, pp. 672-678. DOI: 10.1016/j.clml.2016.08.018

Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation
Pingali, SR & Champlin, RE 2015, Bone Marrow Transplantation, vol 50, no. 9, pp. 1157-67. DOI: 10.1038/bmt.2015.61

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Ciurea, SO, Zhang, M-J, Bacigalupo, AA, Bashey, A, Appelbaum, FR, Aljitawi, OS, Armand, P, Antin, JH, Chen, J, Devine, SM, Fowler, DH, Luznik, L, Nakamura, R, ODonnell, PV, Perales, M-A, Pingali, SR, Porter, DL, Riches, MR, Ringdén, OTH, Rocha, V, Vij, R, Weisdorf, DJ, Champlin, RE, Horowitz, MM, Fuchs, EJ & Eapen, M 2015, Blood, vol 126, no. 8, pp. 1033-40. DOI: 10.1182/blood-2015-04-639831

Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors
Di Stasi, A, Milton, DR, Poon, LM, Hamdi, A, Rondon, G, Chen, J, Pingali, SR, Konopleva, M, Kongtim, P, Alousi, A, Qazilbash, MH, Ahmed, S, Bashir, Q, Al-atrash, G, Oran, B, Hosing, CM, Kebriaei, P, Popat, U, Shpall, EJ, Lee, DA, de Lima, M, Rezvani, K, Khouri, IF, Champlin, RE & Ciurea, SO 2014, Biology of Blood and Marrow Transplantation, vol 20, no. 12, pp. 1975-81. DOI: 10.1016/j.bbmt.2014.08.013

Leptomeningeal carcinomatosis associated with papillary renal cell carcinoma
Chilkulwar, A, Pottimutyapu, R, Wu, F, Padooru, KR, Pingali, SR & Kassem, M 2014, Ecancermedicalscience, vol 8, pp. 468. DOI: 10.3332/ecancer.2014.468

Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission
Pingali, SR, Jewell, SW, Havlat, L, Bast, MA, Thompson, JR, Eastwood, DC, Bartlett, NL, Armitage, JO, Wagner-Johnston, ND, Vose, JM & Fenske, TS 2014, Cancer, vol 120, no. 14, pp. 2122-9. DOI: 10.1002/cncr.28698

Current concepts of clinical management of multiple myeloma
Pingali, SR, Haddad, RY & Saad, A 2012, Disease-a-Month, vol 58, no. 4, pp. 195-207. DOI: 10.1016/j.disamonth.2012.01.006

Proportions of bone marrow lymphocyte subsets at diagnosis may predict survival in patients with newly diagnosed diffuse large B-cell lymphoma independently of the international prognostic index
Zurbriggen, LD, Gundrum, JD, Policepatil, SM, Pingali, SRK, Zeng, GG & Go, RS 2011, American Journal of Hematology, vol 86, no. 7, pp. 622-4. DOI: 10.1002/ajh.22036

Two for one deal
Pingali, SRK 2009, Wisconsin Medical Journal, vol 108, no. 9, pp. 469.

Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation
Pingali, SRK, Mathiason, MA, Lovrich, SD & Go, RS 2009, Clinical Lymphoma and Myeloma, vol 9, no. 5, pp. E25-9. DOI: 10.3816/CLM.2009.n.080